With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Trk-Targeted Therapy of Human Neuroblastomas||Children’s Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia||Children’s Hospital of Philadelphia / Jennifer Wilkes, MD||Young Investigator Grants||2014||Pennsylvania|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children’s Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|
|APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition?||Children’s Hospital of Philadelphia / Abby Green, MD||Young Investigator Grants||2014||Pennsylvania|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Cell Line and Xenograft Repository||Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD||Catalyst Grants||2014||Texas|
|Exploring the Intersection between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes||Baylor College of Medicine / Philip Lupo, PhD||Epidemiology Grants||2014||Texas|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML||Baylor College of Medicine / Michele Redell, M.D./Ph.D.||Springboard Grants||2014||Texas|